ES366965A1 - Infusion solution - Google Patents
Infusion solutionInfo
- Publication number
- ES366965A1 ES366965A1 ES366965A ES366965A ES366965A1 ES 366965 A1 ES366965 A1 ES 366965A1 ES 366965 A ES366965 A ES 366965A ES 366965 A ES366965 A ES 366965A ES 366965 A1 ES366965 A1 ES 366965A1
- Authority
- ES
- Spain
- Prior art keywords
- solution
- moles
- per litre
- infusion solution
- argenine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000003978 infusion fluid Substances 0.000 title abstract 2
- 239000000243 solution Substances 0.000 abstract 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 abstract 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 abstract 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 abstract 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 abstract 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 abstract 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 abstract 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 abstract 2
- 235000019766 L-Lysine Nutrition 0.000 abstract 1
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 abstract 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 abstract 1
- 229930182844 L-isoleucine Natural products 0.000 abstract 1
- 239000004395 L-leucine Substances 0.000 abstract 1
- 235000019454 L-leucine Nutrition 0.000 abstract 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 abstract 1
- 229930195722 L-methionine Natural products 0.000 abstract 1
- 239000004472 Lysine Substances 0.000 abstract 1
- 239000004473 Threonine Substances 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 229960002885 histidine Drugs 0.000 abstract 1
- 238000001990 intravenous administration Methods 0.000 abstract 1
- 229960000310 isoleucine Drugs 0.000 abstract 1
- 229960003136 leucine Drugs 0.000 abstract 1
- 229960004452 methionine Drugs 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 235000016709 nutrition Nutrition 0.000 abstract 1
- 230000035764 nutrition Effects 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 229960005190 phenylalanine Drugs 0.000 abstract 1
- 229960002898 threonine Drugs 0.000 abstract 1
- 229960004799 tryptophan Drugs 0.000 abstract 1
- 229960004295 valine Drugs 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
An infusion solution for intravenous nutrition comprises: 0.0130-0.0850 moles of L-phenyl alanine 0.0165-0.1050 " " L-leucine 0.0145-0.0900 " " L-methionine 0.0025-0.0200 " " L-tryptophan 0.0105-0.0700 " " L-isoleucine 0.0110-0.0700 " " L-lysine 0.0080-0.0550 " " L-threonine and 0.0135-0.0850 " " L-Valine per litre of solution in water, the pH of the solution being adjusted to 4.9 to 7.0 e.g. by the addition of hydrochloric acid or a pharmaceutically acceptable acid. The solution may also contain 0.0125-0.0800 moles of L-argenine and/or 0.0070-0.0450 moles of L-histidine per litre. The solution may have sterile, filtered nitrogen bubbled through it to remove oxygen and is then suitably bottled and autoclaved.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE625968 | 1968-05-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES366965A1 true ES366965A1 (en) | 1971-06-16 |
Family
ID=20268246
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES366965A Expired ES366965A1 (en) | 1968-05-09 | 1969-05-08 | Infusion solution |
Country Status (8)
| Country | Link |
|---|---|
| AT (1) | AT297935B (en) |
| BE (1) | BE732561A (en) |
| DE (1) | DE1923167A1 (en) |
| DK (1) | DK124453B (en) |
| ES (1) | ES366965A1 (en) |
| FR (1) | FR2008137A1 (en) |
| GB (1) | GB1261582A (en) |
| NL (1) | NL6907109A (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2215212B1 (en) * | 1973-01-18 | 1976-03-05 | Seperic Ch | |
| DE2530246A1 (en) * | 1975-07-07 | 1977-01-13 | Fresenius Chem Pharm Ind | L-AMINO ACID MIXTURES FOR PARENTERAL OR ORAL USE |
| JPS5535049A (en) * | 1978-09-04 | 1980-03-11 | Otsuka Pharmaceut Factory Inc | Amino acid transfusion for cancerous patient |
| JPS5536457A (en) * | 1978-09-08 | 1980-03-14 | Ajinomoto Co Inc | Amino acid infusion |
-
1969
- 1969-04-30 AT AT417169A patent/AT297935B/en not_active IP Right Cessation
- 1969-05-06 BE BE732561D patent/BE732561A/xx unknown
- 1969-05-07 DE DE19691923167 patent/DE1923167A1/en active Pending
- 1969-05-07 FR FR6914667A patent/FR2008137A1/fr not_active Withdrawn
- 1969-05-08 ES ES366965A patent/ES366965A1/en not_active Expired
- 1969-05-08 DK DK251169A patent/DK124453B/en unknown
- 1969-05-09 NL NL6907109A patent/NL6907109A/xx unknown
- 1969-05-09 GB GB2387169A patent/GB1261582A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| FR2008137A1 (en) | 1970-01-16 |
| NL6907109A (en) | 1969-11-11 |
| GB1261582A (en) | 1972-01-26 |
| DK124453B (en) | 1972-10-23 |
| BE732561A (en) | 1969-10-16 |
| DE1923167A1 (en) | 1969-11-20 |
| AT297935B (en) | 1972-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE275948T1 (en) | USE OF ADAMANTAN DERIVATIVES FOR PRODUCING A MEDICATION FOR GLAUCOMA TREATMENT | |
| GB1374823A (en) | Triazolylbenzophenones | |
| MX9802734A (en) | Novel stable liquid paracetamol compositions, and method for preparing same. | |
| ATE73657T1 (en) | USE OF GAMMA-LINOLENIC ACID AND RELATED COMPOUNDS IN THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF ENDOMETRIOSIS. | |
| SE7909497L (en) | amino acid salt | |
| ES366965A1 (en) | Infusion solution | |
| EP1632233A4 (en) | PREPARATION OF TRANSFUSIONS FOR PERIPHERAL INTRAVENOUS DELIVERY AND METHOD OF STABILIZING VITAMIN B1 | |
| GB1154742A (en) | Pyrrylamino Ketones | |
| GR74437B (en) | ||
| JPS568312A (en) | Amino acid pharmaceutical preparation | |
| PT76844A (en) | Ester of letronidazole with n,n-dimethylglycine and acid addition salt thereof | |
| MY130107A (en) | Piperidylmethyl-substituted chroman derivatives | |
| IL161665A0 (en) | Method of administering a thymosin alpha 1 peptide | |
| ATE149834T1 (en) | PYRIDYLGUANIDINE COMPOUNDS FOR THE TREATMENT OF ERECTIVE DISORDER | |
| GB1496254A (en) | Nutritive infusion solution and its production | |
| GB1477732A (en) | Nutrient fluids | |
| ES353533A1 (en) | Tetanus vaccine and process for preparing it | |
| ES2162794T3 (en) | PHARMACEUTICAL COMPOUNDS CONTAINING AMETOCAINE. | |
| CY1108781T1 (en) | FISH VACCINE | |
| ES352129A1 (en) | Refining of alpha-6-deoxy-5-oxytetracycline | |
| KR900016092A (en) | Amino acid esters, preparation methods thereof, medicaments containing the same, and uses thereof | |
| JPS58162515A (en) | Electrolyte amino acid infusion for peripheral intravenous infusion | |
| ES422172A1 (en) | Nutrient media | |
| EP0466030A3 (en) | N-acyl dipeptides and their use | |
| Sadakata | Studies on 54Mn uptake by Ehrlich ascites cancer cells in vitro |